News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Analyst recommends tactical long in Selective Insurance at $95 with an $88 stop and $106 target while awaiting H2 underwriting guidance.
  • Modine targets high-margin data-center cooling with a hyperscale deal and planned spinoff, arguing a $13B valuation if margins and recurring revenue sustain.
  • trivago will release Q2 results Aug. 4 after market close and host a management webcast Aug. 5.
  • Gunshot fired outside the U.S. consulate in Toronto, no injuries reported, area sealed and a white sedan fled the scene.
  • This marks the consulate's second shooting in four months amid a string of regional attacks on religious and diplomatic sites.
  • Two buy-side trade ideas focus investor attention on insurance and data-center exposures, highlighting selective risk appetite in those sectors.

Latest Articles

VCI Global Received NASDAQ Notice Related to Late Filing of 20-F

VCI Global Received NASDAQ Notice Related to Late Filing of 20-F

VCI Global Limited disclosed that NASDAQ notified the company of a delayed filing of its 2025 Form 20-F report. The company had previously filed a Form 12b-25 advising the SEC of the delay due to additional time needed for financial review. VCI Global is submitting a compliance plan to NASDAQ and may receive an extension of up to 180 days to regain…

Seer Shares Drop After Board Rejects Revised Buyout Offer

Seer Shares Drop After Board Rejects Revised Buyout Offer

Seer Inc. shares declined 2.3% in after-hours trading following a unanimous board decision to reject a revised unsolicited acquisition proposal submitted on May 14, 2026. The offer, from Bradley L. Radoff, Michael Torok and certain affiliates associated with the Radoff-JEC Group, proposed $2.40 per share in cash plus a contingent value right. Seer’…

Analysis of Executive Stock Sales and Quarterly Performance at InspireMD

Analysis of Executive Stock Sales and Quarterly Performance at InspireMD

InspireMD's Chief Commercial Officer, Shane Gleason, conducted multiple stock sales totaling $189,594. These dispositions were executed through a sell-to-cover election to satisfy tax withholding requirements related to restricted stock vesting. Separately, the company reported Q1 2026 results that surpassed analyst expectations for both earnings p…

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Aktis Oncology announced first-in-human imaging and dosimetry results for AKY-2519, a novel miniprotein radioconjugate targeting B7-H3 expressing tumors, including metastatic castration-resistant prostate cancer and other solid tumors. Data presented at ASCO 2026 demonstrate robust tumor uptake and limited normal tissue exposure, indicating a favor…

WhiteFiber Soars After Securing $160M+ AI Compute Deal for Paris Deployment

WhiteFiber Soars After Securing $160M+ AI Compute Deal for Paris Deployment

WhiteFiber Inc. (NASDAQ:WYFI) shares climbed 11.3% in after-hours trading Thursday after the company disclosed a five-year engagement to supply AI compute infrastructure to an investment-grade technology customer. The agreement, worth more than $160 million over five years, calls for service to begin in July 2026 in the Paris region using advanced …

MOEX Russia Index Closes Higher as Oil & Gas, Power and Mining Lead Gains

MOEX Russia Index Closes Higher as Oil & Gas, Power and Mining Lead Gains

Russian equities ended the trading day higher, with the MOEX Russia Index rising 0.95% at the close in Moscow. Advances were concentrated in the Oil & Gas, Power and Mining sectors. Individual movers included VK Company, Moskovskiy Kreditnyi Bank and Aeroflot among the top gainers, while United Company Rusal and Rosneft were notable decliners. Mark…

Immuneering Shares Rise After Update on Pancreatic Cancer Trial Results

Immuneering Shares Rise After Update on Pancreatic Cancer Trial Results

Immuneering Corporation's stock climbed in after-hours trading following updated Phase 2a results for its pancreatic cancer regimen combining atebimetinib with modified gemcitabine/nab-paclitaxel. The expanded data set shows a 17.3-month median overall survival among 55 first-line metastatic patients and a safety profile consistent with prior repor…

Ross Raises Full-Year Outlook as Bargain-Seeking Shoppers Hold Steady

Ross Raises Full-Year Outlook as Bargain-Seeking Shoppers Hold Steady

Ross Stores increased its full-year comparable sales and earnings per share guidance after reporting a strong first quarter marked by a 17% jump in comparable-store sales and a profit of $2.02 per share. Management cited broad gains in customer counts across income levels, ethnicities and ages, keeping momentum for the off-price channel even amid l…

Director's Activity at Equitable Holdings Signals Internal Accumulation

Director's Activity at Equitable Holdings Signals Internal Accumulation

Equitable Holdings director Francis Hondal has increased his ownership of the company by acquiring shares through dividend reinvestment and receiving a vested stock grant. These transactions occurred while the company reported strong first-quarter earnings that surpassed market expectations, providing an overview of internal confidence amidst recen…

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Black Diamond Therapeutics announced positive Phase 2 clinical trial results of silevertinib, an oral brain-penetrant EGFR inhibitor, in treatment-naïve patients with non-small cell lung cancer (NSCLC) harboring non-classical EGFR mutations. The study demonstrated a median progression-free survival of 15.2 months, a 60% objective response rate, and…

MPLX: The MLP That Deserves a Place in Income Portfolios

MPLX: The MLP That Deserves a Place in Income Portfolios

MPLX pairs a near-8% distribution with stable, fee-based cash flows and multiple growth projects coming online. At $55.65 the unit is trading on reasonable multiples (P/E ~12, EV/EBITDA 14.2) while returning >$5.8B in distributable cash flow and $3.9B in free cash flow. This trade favors a mid-term, income-with-upside approach: enter at $55.65, sto…

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

Autolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026

Autolus Therapeutics announced publication and upcoming presentation of clinical data from the FELIX Phase Ib/II trial on their T cell therapy candidate obe-cel at the ASCO 2026 meeting. The data shows a 59% overall response rate and median duration of response of 42.6 months in adult patients with relapsed/refractory B-cell acute lymphoblastic leu…

Equus Announces First Quarter Net Asset Value

Equus Announces First Quarter Net Asset Value

Equus Total Return, Inc. announced its net asset value (NAV) increased to $1.50 per share as of March 31, 2026, up from $1.19 at the end of 2025. The rise was largely due to a $5 million increase in the value of its holdings in Morgan E&P, Inc., benefiting from higher crude oil prices. Despite a slight decrease in the value of its holdings in Citro…

Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology

Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology

Eikon Therapeutics, Inc. (Nasdaq: EIKN), a late-stage clinical biopharmaceutical company focused on oncology, announced the availability of six abstracts for presentation at the 2026 American Society of Clinical Oncology Annual Meeting. The presentations will highlight updated clinical data and progress for Eikon's advanced drug candidates, includi…

North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders

North American Construction Group Ltd. Announces Voting Results of Annual and Special Meeting of Shareholders

North American Construction Group Ltd. reported the outcomes of its Annual and Special Meeting held on May 20, 2026. Shareholders elected seven directors, approved KPMG LLP as independent auditors, ratified an Advance Notice Bylaw, and passed a non-binding advisory vote on executive compensation. The company operates in heavy civil construction and…

Stardust Power CFO Sells Shares Amid Operational and Valuation Signals

Stardust Power CFO Sells Shares Amid Operational and Valuation Signals

Udaychandra Devasper, the Chief Financial Officer (CFO) of Stardust Power Inc. (NASDAQ:SDST), executed a sale of company common stock totaling $72,625 on May 19, 2026. This transaction, involving 35,776 shares sold at an average price of $2.03 per share, was reported via SEC Form 4 and reportedly covered tax withholding obligations related to the s…